Cyxtera SPAC Presentation Deck

VII Significant EBITDA growth potential through growing utilization Substantial in-place and expansion capacity available to address continued demand Growing utilization could create significant value (¹) ($ in mm, except enterprise value and uplift) Current utilization $220 67% 1 I 26% uplift $57 $220 75% 2021E Adj. EBITDA Note: See "Disclaimer - Statement Regarding Non-GAAP Financial Measures" for the definition of Adj. EBITDA (1) Assumes fixed Revenue per Sq. Ft. and 70% EBITDA margin on incremental revenue. Cyxtera Utilization 54% uplift $118 $220 80% EBITDA Uplift from Utilization Increase 77% uplift $170 $220 85% 30 SVAC

View entire presentation